MARIANNE ALFARO: Open Payments
NPI 1558949990 · SPRING HILL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,441 in 123 payments from 16 companies in 2025. Trend: 2023 $1,983 · 2024 $2,302 · 2025 $2,441
Food & beverage: $2,441
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 25 | $713 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $376 |
| ABBVIE INC. | 13 | $224 |
| Neurocrine BioSciences, Inc. | 9 | $220 |
| Otsuka America Pharmaceutical, Inc. | 20 | $154 |
| Bausch Health US, LLC | 7 | $139 |
| Alkermes, Inc. | 6 | $120 |
| Janssen Pharmaceuticals, Inc | 4 | $93 |
| Corium, LLC | 6 | $83 |
| Noven Therapeutics, LLC | 3 | $74 |
Products named: HETLIOZ, CAPLYTA, FANAPT, VRAYLAR, INGREZZA, REXULTI, APLENZIN, ARISTADA.
Industry payments across FL — which companies pay providers there.
